Imam Abdulrahman Bin Faisal University

King Fahd University of Petroleum and Minerals

Suriya Rehman

Vijaya Ravinayagam

B Rabindran Jermy

Abdulhadi Baykal

Firdos Alam Khan

Mohammad Ashraf Gondal

Rabindran Jermy

Reem Khalid Al-Dakheel

Munirah Abdullah Al-Messiere

Silver and titanium oxide nanoparticles produced withoraqueous extracts and methods for treating bacterial infections or cancer using them.

Method for killing colorectal cancer cells

A medicinal nanocomposite is provided. The medicinal nanocomposite includes 80 to 99 wt. % carrier particles of a porous silicate material selected from a group including mesoporous silica, silicalite, mesosilicalite, silver-incorporated silicalite, and silver-incorporated mesosilicalite, the carrier particles comprising a pore framework, 0.5 to 10 wt. % silver nanoparticles (Ag NPs) disposed the pore framework, and 0.5 to 10 wt. % of a platinum-containing pharmaceutical compound disposed on at least one surface selected from an interior pore surface of the carrier particles, an exterior surface of the carrier particles, and a surface of the silver nanoparticles. The medicinal nanocomposite releases less than 10 mole % of the platinum-containing pharmaceutical compound after 60 to 84 hours at a pH of 4.5 to 7, based on an initial amount of the platinum-containing pharmaceutical compound present in the medicinal nanocomposite.

Solvent-based method for making nanocomposite pharmaceutical material

Method for forming a silver-containing nanocomposite pharmaceutical compound

A medicinal nanocomposite is provided. The medicinal nanocomposite includes 80 to 99 wt. % carrier particles of a porous silicate material selected from a group including mesoporous silica, silicalite, mesosilicalite, silver-incorporated silicalite, and silver- incorporated mesosilicalite, the carrier particles comprising a pore framework, 0.5 to 10 wt. % silver nanoparticles (Ag NPs) disposed on the pore framework, and 0.5 to 10 wt. % of a platinum-containing pharmaceutical compound disposed on at least one surface selected from an interior pore surface of the carrier particles, an exterior surface of the carrier particles, and a surface of the silver nanoparticles. The medicinal nanocomposite releases less than 10 mole % of the platinum-containing pharmaceutical compound after 60 to 84 hours at a pH of 4.5 to 7, based on an initial amount of the platinum-containing pharmaceutical compound present in the medicinal nanocomposite.

Medicinal nanocomposite and method of preparation thereof

Method for quantifying the micronutrient profile oftree leaves (MOLs) using calibration free laser induced breakdown spectroscopy (CF-LIBS).

Quantification of the micronutrient profile intree leaves using calibration free laser induced breakdown spectroscopy

Growing community of inventors

Dammam, Saudi Arabia

Suriya Rehman